Skip to search formSkip to main contentSkip to account menu

Cetuximab-IRDye 800CW

Known as: Cetuximab-IRDye 800, Cetuximab-IRDye800, Cetuximab-IRDye800CW 
An immunoconjugate comprised of the recombinant chimeric monoclonal antibody cetuximab conjugated to the N-hydroxysuccinamide (NHS) ester form of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer
Purpose: Intraoperative near-infrared fluorescence (NIRF) imaging could help stratification for the proper primary treatment for… 
2017
2017
Multi‐modal imaging for assessment of tissue‐engineered bone in a critical‐sized calvarial defect mouse model
Tissue‐engineered bone (TEB) analysis in vivo relies heavily on tissue histological and end‐point evaluations requiring the… 
2015
2015
Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies
Inadequate delivery of therapeutics into tumors has been suggested as a reason for poor response. We hypothesize that bevacizumab… 
2015
2015
Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
For locally advanced and metastatic head and neck squamous cell carcinoma (HNSCC), the current clinical use of Cetuximab in chemo… 
2015
2015
Monitoring Tumor Targeting and Treatment Effects of IRDye 800CW and GX1-Conjugated Polylactic Acid Nanoparticles Encapsulating Endostar on Glioma by Optical Molecular Imaging
Molecular imaging used in cancer diagnosis and therapeutic response monitoring is important for glioblastoma (GBM) research… 
2013
2013
Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast
Ductal carcinoma in situ (DCIS) of the breast is difficult to remove completely during surgery as it is not palpable and can… 
2010
2010
Single dose toxicity study of IRDye 800CW in Sprague-Dawley rats
Fluorophore-labeled contrast imaging agents are moving toward clinical use as aids in nodal staging and intraoperative resection… 
2009
2009
A wortmannin-cetuximab as a double drug.
Double drugs are obtained when two pharmacologically active entities are covalently joined to improve potency. We conjugated the… 
2009
2009
The Next Step in Near Infrared Fluorescence: IRDye® QC-1 Dark Quencher
Cells, tissues, plastics, blotting membranes, and chemical compound libraries all exhibit autofluorescence that can interfere… 
Highly Cited
2004
Highly Cited
2004
Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)